Introduction
============

More than 30% of newly synthesized proteins are misfolded because of errors in translation or post-translational processes ([@B167]). Molecular chaperones, primarily heat shock proteins, recognize these proteins and attempt to facilitate their refolding ([@B31]). Two proteolytic mechanisms, the ubiquitin-proteasome system (UPS) and the autophagy-lysosomal pathway (ALP), are responsible for cellular clearance of misfolded proteins which are unable to be refolded. The ALP includes three autophagic processes in mammals, namely macroautophagy, chaperone-mediated autophagy (CMA), and microautophagy ([@B144]), which use different mechanisms to deliver their cargo to lysosomes for enzymatic degradation. Misfolded proteins are initially subjected to removal by the UPS and selected proteins may also be removed by CMA. Misfolded proteins which avoid clearance by these mechanisms may be removed by macroautophagy ([@B30]). Protein oligomers, soluble aggregates, and intact organelles are too large to enter the proteasome's narrow opening, so they can be degraded by the ALP but not by the UPS ([@B11]; [@B197]). Cross-talk is present between CMA and macroautophagy so that if one mechanism is impaired, the activity of the other may increase in an effort to maintain protein homeostasis ([@B117]; [@B197]). Clearance of misfolded proteins is critical for cell survival because misfolding alters a protein's three-dimensional structure, impairing its biological activities and increasing its propensity to form toxic aggregates ([@B68]). Misfolded and aggregated proteins are key pathological findings in several chronic neurodegenerative diseases including Alzheimer's disease (AD) ([@B169]), Parkinson's disease (PD) ([@B178]), Huntington's disease ([@B70]), amyotrophic lateral sclerosis ([@B131]), and prion disorders ([@B94]); not surprisingly, dysregulation of the UPS and the ALP has been reported in some of these disorders ([@B9]; [@B193]; [@B5], [@B6]; [@B162]; [@B132]; [@B208]; [@B18]; [@B62]). Because aging is the most consistent known risk factor for progressive neurodegenerative disorders ([@B79]), the impairment of proteolytic mechanisms in these disorders may be due in part to an age effect ([@B104]; [@B199]).

The biological changes that occur in aging cells include alterations in proteostatic mechanisms, chromosome regulation, transcriptional regulation, protein translation, mitochondrial functioning, and cytoskeletal integrity ([@B46]). This review will focus on studies that have examined age-related changes in macroautophagy and CMA in the central nervous system (CNS) including the brain, cerebrospinal fluid (CSF), and retina. For comparative purposes, findings from studies which have investigated age-associated changes in these processes in non-CNS experimental systems will also be summarized.

Autophagy Overview
==================

Autophagy involves degradation of cytoplasmic contents within the lysosome, followed by recycling of the resulting macromolecular constituents including amino acids, sugars, lipids, and nucleic acids ([@B55]; [@B197]; [@B73]). Macroautophagy ([Figure 1](#F1){ref-type="fig"}), the best studied of these mechanisms, involves sequestering of cytoplasmic cargo into an autophagosome followed by lysosomal degradation of the cargo ([@B90]). A double-membraned structure, the phagophore, initially forms around bulk cytoplasm and its constituents ("non-selective macroautophagy") or specific cytoplasmic targets including organelles ("selective macroautophagy"). The origin of the components which comprise the phagophore membrane is unclear; it has been suggested to derive from multiple sources including plasma membrane, endoplasmic reticulum, mitochondria, and the Golgi apparatus ([@B111]). Once autophagy is initiated, double-membrane nucleation allows formation of a phagophore which elongates, sequesters the cargo, and closes to form an autophagosome. The autophagosome then fuses with a lysosome to form an autolysosome ([@B168]; [@B125]; [@B159]). Sequestered constituents are rapidly degraded by lysosomal hydrolytic enzymes. The term "autophagic flux," which is a measure of autophagic degradation activity ([@B108]), is used to refer to the complete process which starts with autophagosome formation and ends with the release of macromolecules into the cytosol ([@B206]). Quantification of autophagic flux requires multiple measurements of macroautophagy markers over time to determine the rate of the process ([@B108]).

![Macroautophagy. Induction of macroautophagy results in phagophore formation, which requires the kinase Vps34 (functioning in a complex that contains Atg6, whose mammalian homolog is Beclin 1). This is followed by phagophore membrane elongation, which is regulated by LC3-II. The phagophore closes around sequestered cargo, resulting in formation of a mature autophagosome. The autophagosome moves along microtubules to a lysosome and fuses with it. Cargo is then degraded by lysosomal enzymes and breakdown products are recycled to the cytosol. The complete process is termed autophagy flux (Reprinted from [@B159]).](fnagi-11-00049-g001){#F1}

Much of what is known about the induction of macroautophagy comes from studies with yeast, where 41 autophagy-related proteins, known as Atgs, have been identified to date ([@B140]; [@B150]). Approximately half of these proteins are known to have homologs in higher eukaryotes ([@B91]). The proteins necessary for autophagosome formation are referred to as "core molecular machinery" ([@B198]). The proteins involved in macroautophagy in mammals are similar but not identical to those in yeast; several reviews of the process in mammalian systems have appeared ([@B52]; [@B120]; [@B201]; [@B2]). The core molecular machinery has been divided into functional groups ([@B201]; [@B140]): (a) the Atg1 kinase complex \[in mammals, the Atg1/unc-51-like kinase (ULK) complex\], (b) the Atg12-conjugation system, (c) the Atg8/microtubule-associated protein light chain 3 (LC3)-conjugation system, (d) the Vps34 phosphoinositide 3-kinase (PI3 kinase) complex, (e) the Atg9 and Atg2-Atg18 complex, and (f) vacuole-membrane-protein-1 (VMP1). ULK-1 and ULK-2 are mammalian proteins with close homology to Atg1. The Atg1/ULK complex, composed of ULK1 or ULK2, mAtg13 (the mammalian homolog of Atg13), Atg101, and FIP200 (the homolog of yeast Atg17), regulates macroautophagic activity by detecting changes in concentrations of constituents such as glucose, growth factors, nitrogen, amino acids, and reactive oxygen species ([@B88]). When nutrients are sufficient, mammalian TOR complex 1 (mTORC1) is included in this complex, but mTORC1 dissociates from it when nutrients are limiting. Macroautophagy can be induced by multiple mechanisms ([@B159]) including caloric restriction or treatment with rapamycin, both of which inhibit mTORC1. A decrease in mTOR's kinase activity results in dephosphorylation of ULK1, ULK2, and mAtg13, which activates ULK1 and ULK2. ULK1 and ULK2 phosphorylate mAtg13 and FIP200, which initiates autophagosome formation ([@B74]). Beclin 1, the mammalian homolog of Atg6, participates with other subunits in forming the PI3 kinase complex ([@B197]). The Atg12 and Atg8/LC3 conjugation systems are involved with elongation and expansion of the phagophore membrane ([@B201]). The Atg8-conjugation system conjugates Atg8 (and, in mammals, LC3) to phosphatidylethanolamine (PE). PE-conjugated LC3 is referred to as LC3-II, whereas its unconjugated counterpart is known as LC3-I. LC3-II regulates phagophore membrane elongation ([@B1]) and facilitates membrane tethering and hemifusion ([@B136]). The Vps34 PI3 kinase complex is a positive regulator of macroautophagy; its activity generates phosphatidylinositol 3-phosphate, which recruits the Atg2--Atg18 complex to bind to Atg9 on autophagic membranes ([@B141]). Atg9 also carries membranes from donor organelles between the developing autophagosome and the periphery. VMP1, a mammalian protein which does not appear to have an equivalent in yeast, induces autophagy even when nutrients are adequate by binding to Beclin 1, leading to the formation of a complex with Vps34 ([@B127]). UV radiation-associated resistance gene (UVRAG) and Beclin 1-associated autophagy related key regulator (Barkor) stabilize the Beclin 1/Vps34 complex ([@B100]; [@B177]). Other important regulators of macroautophagy include AMP-activated protein kinase (AMPK) ([@B122]) and the PI3K/Akt/mTOR pathway ([@B196]). AMPK is activated by low ATP or glucose concentrations. Its activation can induce macroautophagy by inactivating TORC1 and by phosphorylating ULK1 ([@B66]). Conversely, signaling from the PI3K/Akt/mTOR complex leads to phosphorylation, and thus activation, of mTOR ([@B185]), which inhibits macroautophagy ([@B21]).

Markers which have been used to measure macroautophagy (reviewed by [@B90]) include the proteins encoded by Atg5 ([@B32]) and Atg12 ([@B63]), Beclin 1 ([@B82]), mTOR ([@B14]), and LC3 ([@B176]), including LC3-I, LC3-II, and the LC3-II/LC3-I ratio. LC3-II is initially found on inner and outer layers of the phagophore membrane. During autophagosome maturation, it is removed from the outer (cytosolic) surface due to cleavage of PE by Atg4 ([@B204]), but remains on the inner (lumenal) surface of the autophagosome. LC3-II levels therefore correlate with autophagosome numbers ([@B126]; [@B197]). The LC3-II/LC3-I ratio is often examined by Western blot at a single time point to assess changes in macroautophagic activity, but this procedure does not actually measure autophagic flux because no rate of change is measured ([@B108]). Alterations in LC3-II and in the LC3-II/LC3-I ratio can be difficult to interpret, because an increase in the LC3-II level may be due to either activation of macroautophagy or a decrease in autophagosomal-lysosomal fusion or lysosomal degradation of cargo; similarly, a reduction in LC3-II may be due to inhibition of macroautophagy or to an increase in autophagic flux ([@B103]). Preventing lysosomal degradation of autophagosomal LC3-II, by including inhibitors of autophagosome-lysosome fusion or of lysosomal proteases in the experimental system, may be necessary to interpret LC3-II and LC3-II/LC3-I measurements ([@B90]; [@B145]). Other markers that have been used to investigate changes in macroautophagy include the lysosomal protease cathepsin D ([@B183]) and the autophagic adaptor proteins p62/Sequestosome-1 (known as p62/SQSTM1 or p62) ([@B105]) and its functional homolog, neighbor of BRCA1 (NBR1) ([@B89]). The latter two proteins are macroautophagy substrates; however, similar to the situation with LC3-II, single measurements of these proteins provides no information about their rate of turnover ([@B108]).

Chaperone-mediated autophagy ([Figure 2](#F2){ref-type="fig"}), a more selective autophagic mechanism than macroautophagy which has been identified only in mammals, does not involve vesicle formation ([@B35]). Its selectivity is due to the requirement for its substrate proteins to contain amino acid sequences biochemically similar to Lys-Phe-Glu-Arg-Gln (KFERQ), which is present in approximately 30% of cytosolic proteins ([@B45]; [@B27]; [@B28]). Proteins bearing this sequence are bound by the molecular chaperone heat shock 70 kDa protein 8 (HSPA8, also known as hsc70 and hsc73; hereafter, "HSPA8/hsc70") in association with co-chaperones ([@B4]). The protein-HSPA8/hsc70 complex then binds to a lysosomal surface receptor, lysosome-associated membrane glycoprotein 2a (lamp2a), which facilitates its translocation into the lysosomal lumen. Binding of the protein-HSPA8/hsc70 complex to lamp2a is rate-limiting for CMA ([@B36]) so the concentration of lamp2a on lysosomal membranes is considered to be a marker for CMA ([@B38]; [@B147]). In CMA, substrate proteins must unfold before their translocation into the lysosomal lumen. This unfolding is facilitated by HSPA8/hsc70 and its co-chaperones ([@B163]). Only lysosomes containing HSPA8/hsc70 on the lumenal side of the lysosomal membrane are capable of performing CMA ([@B147]). The percentage of CMA-competent lysosomes in the rat liver is 20--30% under basal conditions but can increase to 80% during starvation ([@B33]).

![Chaperone-mediated autophagy (CMA). (i) Substrate proteins with an amino acid sequence biochemically similar to KFERQ are recognized by HSPA8/hsc70 in association with co-chaperones. (ii) This complex binds to the monomeric form of a lysosomal surface receptor, lamp2a, which will facilitate its translocation into the lumen of the lysosome. (iii) Binding of the substrate to lamp2a causes lamp2a to multimerize into a translocation complex. (iv) After unfolding, the substrate translocates into the lysosomal lumen. The presence of a lysosomal luminal form of HSPA8/hsc70 is required for this translocation to occur. (v) The substrate is quickly degraded by lysosomal hydrolytic enzymes. (vi) Lamp2a disassembles from its translocation complex, facilitated by HSPA8/hsc70. (Reprinted from [@B35]).](fnagi-11-00049-g002){#F2}

Microautophagy has been less studied than the other autophagic mechanisms. In this process the lysosomal membrane directly engulfs portions of cytoplasm and the constituents within it. This process can be non-selective (degradation of randomly sequestered cytosol) or selective (degradation of specific organelles such as mitochondria, portions of the nucleus, or peroxisomes) ([@B54]; [@B123]). Little is known about the factors that regulate microautophagy in mammalian cells ([@B123]).

Cross-Talk Between Autophagic Mechanisms
========================================

Both CMA and macroautophagy are maximally activated by stress conditions such as starvation and oxidative stress ([@B85]). Cross-talk occurs between these two autophagic mechanisms ([Figure 3](#F3){ref-type="fig"}) (reviewed by [@B197]); if the activity of one is reduced, the activity of the other may increase in an effort to maintain protein homeostasis ([@B40]; [@B117],[@B118], [@B116]; [@B85]; [@B194]). For example, while macroautophagy is initially upregulated due to nutrient deprivation, if this condition continues it becomes downregulated, with compensatory activation of CMA ([@B39]; [@B117]). Conversely, blockage of CMA by inhibitory RNA targeting of lamp2a initially results in a decline in macroautophagy due to increased mTOR activity, but if CMA blockage continues then macroautophagy becomes activated as indicated by increased levels of Beclin 1. In a cell model of tauopathy, failure of CMA to clear mutated tau led to formation of tau aggregates, which could be cleared by macroautophagy ([@B194]). The signaling mechanisms in this cross-talk are incompletely understood; proteins suggested by [@B197] to be involved in this process include HSPA8/hsc70 ([@B189]), p53 ([@B181]), nuclear factor (erythroid-derived 2)-like 2 (Nrf2) ([@B58]), and ubiquilin ([@B158]). Reduced phosphorylation of mTOR may play a role in the compensatory increase in macroautophagy when CMA is impaired ([@B116]), and when macroautophagy is inhibited, compensatory upregulation of CMA can occur through increasing lysosomal concentrations of lamp2a and HSPA8/hsc70 ([@B85]; [@B92]). Upregulation of CMA may not fully compensate for impairment in macroautophagy, and vice versa ([@B118]; [@B197]). The cross-talk between the autophagic processes is not always bidirectional. [@B154] found an age-associated decrease in macroautophagy (decreased LC3-II/LC3-I ratio and reduced mRNA expression of Beclin 1 and Atg7) in the mouse retina, which was accompanied by an increase in CMA (increased lysosomal levels of lamp2a and HSPA8/hsc70). A similar result was obtained *in vitro* by shRNA-mediated knockdown of Atg7 expression in the 661W mouse retinal cell line. However, inhibition of CMA in these cells (by downregulating lamp2a) did not result in an increase in macroautophagy. The interactions between CMA and macroautophagy have been suggested to delay the accumulation of abnormal proteins, perhaps contributing to the association between aging and neurodegenerative disorders ([@B41]).

![Cross-talk between macroautophagy and CMA. If the activity of one of these autophagic processes is reduced, the activity of the other may increase in a compensatory manner. Continued blockage of CMA by inhibitory RNA targeting of lamp2a results in activation of macroautophagy as indicated by increased levels of Beclin 1; conversely, while nutrient deprivation initially upregulates macroautophagy, continued nutrient deprivation downregulates it with compensatory activation of CMA. However, this compensation may not be bi-directional, and the upregulation of one mechanism may not fully compensate for impairment of the other one. The signaling mechanisms involved in this cross-talk, while poorly understood, may include HSPA8/hsc70, p53, Nrf2, and/or ubiquilin (Reprinted from [@B197]).](fnagi-11-00049-g003){#F3}

Influence of Normal Aging on Autophagy in Human Brain and CSF
=============================================================

Few studies have been performed on the effects of normal aging on autophagy in human brain or CSF. The findings in these studies are summarized in [Table 1](#T1){ref-type="table"}. Three gene expression studies with human brain have found age-associated reductions in macroautophagy markers. [@B170] found downregulation of Beclin 1, and [@B104] found decreases in autophagy-regulating genes including Atg5 and Atg7. [@B61], investigating the effects of gender and aging on gene transcription in the hippocampus, reported decreased expression of LC3, HDAC6 (a deacetylase required for autophagosomal maturation and fusion with lysosomes) ([@B97]), and PINK1 (a mitochondrial kinase whose activity is crucial to mitochondrial function) ([@B151]) in older women. In older men expression of Bcl-2, which inhibits Beclin 1 ([@B101]), was increased, suggesting a decrease in macroautophagic activity. Conversely, expression of BAG-2, which inhibits PINK1 degradation by blocking its ubiquitination, and therefore triggers PARKIN-mediated mitophagy ([@B151]), was also increased in older men, suggesting activation of mitophagy. Notably, no studies were found of the effects of normal aging on CMA activity in human brain.

###### 

Influence of normal aging on autophagy in human brain and CSF.

  Study     Results
  --------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B170]   Beclin 1 expression decreased in age-dependent fashion in human brains.
  [@B104]   Genome-wide analysis found transcriptional downregulation of key macroautophagy genes including Atg5 and Atg7 in older (\>70 years old) vs. younger (\<40 years old) human brains.
  [@B7]     Proteomics study on CSF from cognitively normal adults; three proteins in autophagy category of gene ontological analysis were positively associated with age.
  [@B61]    Influence of sexual dimorphism and aging on gene transcription in hippocampus: expression of LC3 and HDAC6 decreased in older women; in older men, expression of bcl-2, which inhibits Beclin 1, was increased. However, BAG-2, which can trigger PARKIN-mediated mitophagy, also increased in older men.
  [@B107]   HSPA8/hsc70 in CSF from healthy subjects was negatively correlated with age.
  [@B106]   Lamp2 concentration in CSF changed little during normal aging.

Three gene expression studies on human postmortem brain specimens have found age-associated decreases in macroautophagy markers. No studies of the effects of normal aging on CMA activity in human brain were found. Three studies of age-related changes in CSF autophagy proteins have produced conflicting results

.

Three studies have examined the effects of normal aging on autophagy-related proteins in CSF. A proteomics analysis found CSF concentrations of three proteins with the gene ontology classification of "autophagy," namely myoglobin, MMP8, and HMW kininogen, to be positively correlated with age ([@B7]). Conversely, the CSF concentration of HSPA8/hsc70 was found to decrease with age ([@B107]) while the CSF level of lamp2 changed little ([@B106]). Lamp2 is not a marker for a specific autophagic process, because in addition to the previously discussed role of lamp2a in CMA ([@B37]), lamp2 has two other isoforms which also participate in autophagic processes ([@B139]; [@B56]).

Influence of Normal Aging on Autophagy in the CNS in Experimental Models
========================================================================

Studies of the relationship between aging and brain macroautophagy, including age-related changes in macroautophagy markers and the effects of impairing macroautophagy (for example, by introducing mutations in Atg genes) on lifespan, are shown in [Table 2](#T2){ref-type="table"} for experimental animal models. This table is not all-inclusive; additional references can be found in recent reviews by [@B64] and [@B133]. Macroautophagy has been shown to be required for normal lifespan in *Caenorhabditis elegans* and *Drosophila* ([@B121]; [@B67]; [@B171]; [@B124]) and enhancement of macroautophagic activity, for example by upregulation of AMPK or rapamycin-mediated inhibition of TOR, increases lifespan in these models ([@B191]; [@B171]; [@B12]; [@B186]). However, conflicting results were found by [@B69], who reported that knockout of some autophagy genes in daf-2 mutant *C. elegans* mutants increased rather than decreased their lifespan. Also in C. elegans, [@B161] found an age-associated loss of macroautophagic function in dopamine neurons. A recent review by [@B133] concluded that "basal level of autophagic activity is elevated in many longevity paradigms and the activity is required for lifespan extension." The effects of aging on brain macroautophagy have also been investigated in mice ([@B65]; [@B93]; [@B57]; [@B83]; [@B185]; [@B146]), rats ([@B203]), and cows ([@B42]). Mice lacking Atg7 in the CNS developed neuronal loss and died within 28 weeks ([@B93]), and mice deficient for Atg5 in neural cells developed progressive motor deficits in conjunction with neuronal inclusion bodies ([@B65]). An association was reported between activation of macroautophagy and retention of spatial memory during aging; mice that were subjected to caloric restriction for 10 months, beginning at 6 weeks of age, performed better on Morris water maze testing than mice fed a high calorie diet, and the mice subjected to caloric restriction had higher hippocampal levels of Beclin 1, LC3, and cathepsin B and lower levels of mTOR and p62 than the high-calorie group ([@B51]). [@B83] and [@B146] reported age-related decreases in macroautophagy markers in mouse brain, and similar findings were reported by [@B203] in rat brain. Brain levels of Beclin 1 were found to decline in old naked mole-rats, the longest-lived rodent, suggesting an age-associated decrease in macroautophagy in this species as well ([@B185]). [@B154], examining age-related changes in autophagic mechanisms in mouse retina, found lower Beclin 1, and lower LC3-II after lysosomal blockage, in older mice, and [@B42] found lower Beclin 1 but an increase in the LC3-II/LC3-I ratio in old cow brain specimens. In conflict with these results is a study by [@B57] which reported increased total cathepsin and cathepsin B activity in old mouse brain. In that study, aging was associated with a switch of regulatory control over degradation of polyubiquitinated proteins in mouse brain from Bcl-2-associated athanogene-1 (BAG1), a regulator of proteasomal degradation pathways ([@B110]), to BAG3, a stimulator of macroautophagy ([@B24]), suggesting that aged cells may rely more on macroautophagy for degrading polyubiquitinated proteins.

###### 

Influence of normal aging on CNS macroautophagy in experimental systems.

  Study     Results
  --------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B121]   Knockdown of bec-1 (*C. elegans* homolog of mammalian APG6/VPS30/beclin1) prevented lifespan extension in *daf-2 C. elegans* mutants.
  [@B191]   TOR deficiency in *C. elegans* increases its lifespan.
  [@B65]    Mice deficient for Atg5 in neural cells developed progressive motor deficits together with neuronal inclusion bodies.
  [@B93]    Mice lacking Atg7 in the CNS developed behavioral defects and died within 28 weeks. Neuronal loss was present in cerebral and cerebellar cortices, with age-related accumulation of polyubiquitinated proteins as neuronal inclusion bodies.
  [@B67]    Knockdown of atg7 and atg12 shortened the lifespan of both wild type and insulin/IGF-1 receptor *daf-2* mutant *C. elegans*.
  [@B171]   Expression of several autophagy genes in *Drosophila* neural tissues decreases with aging. Atg8a mutations reduce lifespan and increase sensitivity to oxidative stress.
  [@B69]    Knockout of macroautophagy genes tended to reduce lifespan in wild type *C. elegans*, but knockout of any of seven autophagy genes in *daf-2 C. elegans* mutants increased lifespan.
  [@B57]    Increased BAG-3 (regulator of macroautophagy) and decreased BAG-1 (regulator of proteasomal pathways) were found in brain regions of old mice.
  [@B12]    Inhibition of TOR by rapamycin increased lifespan in *Drosophila*.
  [@B83]    22-month-old mice had lower levels of Atg7, LC3-II, p62, and NBR1 in hypothalamus than 3-month-old mice.
  [@B154]   No differences in basal levels of LC3-II in retinas between 3- and 22-month-old mice, but in contrast to findings in young mice, no increase in LC3-II occurred in the old mice after lysosomal blockage. mRNA for beclin-1 and Atg7 was decreased in the older animals, and protein levels of the macroautophagy substrate p62 were increased.
  [@B51]    An association was found between induction of macroautophagy activity (by caloric restriction) and retention of spatial memory during aging in mice. Caloric restriction resulted in higher hippocampal levels of Beclin 1, total LC3, and cathepsin B and lower levels of mTOR and p62.
  [@B161]   Age-related inhibition of macroautophagy in dopaminergic neurons after *C. elegans* finished reproductive period.
  [@B146]   Beclin 1, p62, and ATG5-ATG12 decreased with age, and mTOR increased with age, in C57BL6 mouse brain.
  [@B185]   Beclin 1 decreased in whole-brain homogenates from old naked mole-rats, while the LC3-II/LC3-I ratio did not change with age.
  [@B42]    Old cow brain specimens had higher LC3 immunoreactivity, lower Beclin 1 immunoreactivity, and increased LC3-II/LC3-I ratio compared to young cow brain specimens.
  [@B124]   A mutation in the atg-18 gene reduces *C. elegans* lifespan. Expression of atg-18 in neurons or intestinal cells restores normal lifespan, with similar results in *daf-2* mutants.
  [@B203]   24-month old Wistar rats had lower hippocampal Beclin 1 and LC3-II than 5-month-old rats.

Most studies in

C. elegans

and

Drosophila

have reported decreased brain macroautophagy with aging. Macroautophagy has been shown to be required for normal lifespan in these models. In mouse brain, macroautophagy markers decrease with aging. Knockout of critical Atgs results in neurodegeneration and shortened lifespan in mice

.

Few studies have investigated the effects of normal aging on CMA in the CNS in experimental models. The results from these studies are summarized in [Table 3](#T3){ref-type="table"}. Three studies examined the influence of normal aging on the concentration of HSPA8/hsc70 in rat brain. Two of these reported an increase ([@B188]; [@B20]) while the third one found a decrease ([@B60]). In the study discussed above in which an age-related decrease in macroautophagy was found in mouse retina ([@B154]), CMA was reported to increase with normal aging, possibly to compensate for the decrease in macroautophagy.

###### 

Effects of normal aging on CNS CMA in experimental systems.

  Study     Results
  --------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B188]   HSPA8/hsc70 in pons, medulla, striatum, and thalamus was higher in 24- than in 6-month-old Wistar rats.
  [@B20]    Age-related increase in HSPA8/hsc70 in rat brain between 6 and 28 months of age; highest levels in hippocampus and substantia nigra, followed by cerebellum, cortex, septum and striatum.
  [@B154]   An age-related increase was found in lamp2a and HSPA8/hsc70 concentrations in mouse retina, possibly to compensate for the age-related decrease in macroautophagy. However, in cultured cone retinal cells, CMA blockade did not result in an increase in macroautophagy.
  [@B60]    HSPA8/hsc70 was lower in striatum, but not in substantia nigra, of old vs. young female rats.

Few studies have been performed to investigate the effects of normal aging on CMA in the CNS in experimental animal models. Two studies have reported an age-related increase in HSPA8/hsc70 in rat brain while a third one found a decrease. In mouse retina, an age-related increase in CMA was detected, possibly in compensation for an age-related decrease in macroautophagy

.

Influence of Normal Aging on Autophagy in Experimental Systems Other Than the CNS
=================================================================================

The experimental models that have been used most frequently to examine the effects of aging on macroautophagy in non-CNS systems are human fibroblast cultures ([@B182]; [@B146]; [@B149]; [@B157]) and rat liver, in which Bergamini and colleagues have extensively investigated the effects of caloric restriction on macroautophagy and its endocrine regulation ([@B192]; [@B25], [@B26]; [@B48],[@B49], [@B50], [@B47]; [@B43]). Studies have also been performed in mouse liver ([@B184]), rat heart ([@B195]), mouse muscle ([@B115]; [@B23]), mouse heart ([@B78]; [@B179]; [@B13]; [@B209]), rat nucleus pulposis ([@B202]), and human muscle biopsies ([@B23]). The results in these studies are summarized in [Table 4](#T4){ref-type="table"}. Most studies using Beclin 1 as a marker for macroautophagy have found an age-related decrease, while conflicting results have been obtained with measurements of LC3-II and LC3-II/LC3-I.

###### 

Influence of normal aging on macroautophagy in experimental systems other than the CNS.

  Study     Results
  --------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B184]   Decreased rate of formation of autophagic vacuoles, and decreased rate of their elimination, in hepatocytes from old (20--21 months) CBA mice.
  [@B192]   Reduced hepatic macroautophagy in old Sprague-Dawley rats, partially prevented by dietary restriction.
  [@B48]    Maximum rate of autophagic proteolysis reached at 6 months in Sprague-Dawley rats and declined thereafter.
  [@B49]    Autophagy in isolated liver cells of Sprague-Dawley rats exhibited age-related decline after 6 months.
  [@B43]    Autophagic-proteolytic response of liver to an anti-lipolytic agent was maximal in 1-month-old Sprague-Dawley rats, decreased in 6-month-old rats, and almost negligible in older rats.
  [@B26]    Oxidized mitochondria accumulated in older Sprague-Dawley rat liver rather than degradation by autophagy.
  [@B195]   Beclin 1 increased in heart from 26-month old vs. 6-month old Fisher 344 rats.
  [@B50]    Autophagic response to glucagon and insulin decreased in isolated hepatocytes from older rats.
  [@B202]   Increased LC3-II and LC3-II/LC3-I ratio in nucleus pulposis of 24 month-old vs. 3 month-old Sprague-Dawley rats.
  [@B23]    Age-associated decrease in LC3-II and Atg7 in muscle from older humans and mice.
  [@B182]   Increased autophagosome number and LC3-II, but no change in Beclin 1 or Atg5, in skin fibroblasts from older women.
  [@B146]   Decreased LC3-II/LC3-I ratio, p62, ATG5--ATG12, and beclin-1 in older (60 doublings) vs. younger (20 doublings) human dermal fibroblasts; higher mTOR (macroautophagy inhibitor) in old fibroblasts.
  [@B149]   Reduced mRNA expression of LC3-II in synchronized aged normal human skin fibroblasts compared to young skin fibroblasts.
  [@B157]   Reduced induction of autophagy in aged human primary lung fibroblasts.
  [@B209]   Decreased autophagic degradation of p62 in skeletal and cardiac muscle in 27-month old vs. 5-month old mice, and decreased LC3-II/LC3-I ratio in skeletal muscle from aged mice.

Many studies have been performed to examine the effects of aging on macroautophagy in rat liver and human fibroblasts. Most studies have found an age-related decrease.

Studies on the effects of aging on CMA in experimental systems other than the CNS are summarized in [Table 5](#T5){ref-type="table"}. The initial studies on CMA were done by Dice and his colleagues ([@B44]; [@B143]; [@B119]; [@B45]; [@B27]; [@B28]; [@B36]). [@B37] reported that CMA decreased in lysosomes from aged rat livers and late-passage human fibroblasts, in association with an age-associated decrease in lamp2a on lysosomal membranes. Their finding of an age-related decrease in CMA in rat liver has been confirmed and extended in subsequent studies ([@B84]; [@B87]; [@B205]; [@B10]; [@B155]; [@B165]). Age-related changes in CMA have also been studied in mouse skeletal and cardiac muscle ([@B209]) and rat nucleus pulposis ([@B202]), with conflicting results. An age-associated decrease in lamp2 gene expression was reported for human leukocytes ([@B76]) but as discussed above, lamp2 measurements are not specific for CMA.

###### 

Effects of normal aging on CMA in experimental systems other than the CNS.

  Study     Results
  --------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B143]   Reduced ability of late-passage confluent human fibroblasts to degrade long-lived, but not short-lived, proteins in absence of growth factors.
  [@B37]    CMA decreased in lysosomal membranes from aged (22 month-old) vs. young (3 month-old) rat liver, and in higher-passage (52 population doublings) vs. lower passage (22 population doublings) human fibroblasts. Age-related reduction in lamp2a at lysosomal membrane in both systems. Increased hsc73 (HSPA8/hsc70) at hepatic lysosomal membrane in old rats; may be compensatory response to age-related reduction in CMA.
  [@B87]    Age-related decline in CMA in rat liver due to altered dynamics and stability of lamp2a at lysosomal membrane. Rate of transcription of lamp2a unchanged with age.
  [@B84]    Age-related changes in lipid composition of discrete microdomains at the lysosomal membrane found to be responsible for reduced lysosomal levels of lamp2a with aging in rat hepatocytes.
  [@B205]   Age-related decline in CMA prevented in transgenic mouse in which lysosomal membrane lamp2a concentration was modulated. Preservation of autophagic activity resulted in reduced intracellular accumulation of damaged proteins.
  [@B202]   Increased lamp2a, but decreased HSPA8/hsc70, in nucleus pulposis of 24 month-old vs. 3 month-old Sprague-Dawley rats.
  [@B76]    Age-related decrease in lamp2 gene expression in human leukocytes.
  [@B156]   Chronic exposure to high-fat diet or acute exposure to cholesterol-enriched diet decreased hepatic CMA in mice due to lower lamp2a at lysosomal membrane. Changes in lipid composition of the lysosomal membrane of lipid-challenged animals were similar to changes caused by aging.
  [@B165]   In a mouse model with liver-specific CMA deficits, other proteolytic systems were able to compensate for these deficits in young mice but not in older mice.
  [@B209]   Lamp2a and HSPA8/hsc70 decreased in skeletal muscle of aged (27 months old) vs. young (5 months old) C57BL/6 mice; in cardiac muscle of aged mice, lamp2a increased while HSPA8/hsc70 was unchanged.

Most studies have examined this issue in rat liver, and have reported an age-related decrease in CMA. Similar findings were reported for late-passage human fibroblasts, while conflicting results have been found for mouse skeletal and cardiac muscle and rat nucleus pulposis

.

Influence of Normal Aging on Lysosomal Activity
===============================================

Normal aging has been associated with decreased lysosomal activity ([@B152]; [@B22]). Successful autophagic removal of proteins requires an efficiently functioning lysosomal pool, so a decline in lysosomal activity could play a prominent role in age-related deficits in macroautophagy and CMA. Lysosomal hydrolytic enzymes include proteases, nucleases, lipases, sulfatases, and phosphatases, whose optimal pH range is 4.5--5 ([@B22]). In yeast, lysosomal pH is a regulator of lifespan and mitochondrial function ([@B77]; [@B160]). Lysosome numbers and their size increase in senescent cells ([@B153]; [@B15]; [@B95]), possibly due to accumulation of non-degradable constituents such as lipofuscin in autophagic vacuoles ([@B16]). Lipofuscin accumulates during normal aging in lysosomes of neurons and other post-mitotic cells, where it may exert deleterious effects on autophagy if lysosomal enzymatic activity is expended in an effort to degrade it ([@B17]). The literature contains conflicting results with regard to age-related changes in the activities of different lysosomal proteases in the CNS. [@B86] and [@B134] reported that cathepsin D activity increased in the aged rat brain, and [@B135] found increases in cathepsin D, E, and B activities, but decreased cathepsin L activity (although not in cathepsin L protein), in brain regions from older rats. Cathepsin D localized primarily to lysosomes in young rat cerebral cortical neurons, but diffuse cytosolic immunoreactivity was also present in older rats, possibly contributing to age-related cell death ([@B81]). (See [@B174] for a review of the regulation of lysosomal cathepsins in aging and neurodegeneration and their contribution to apoptotic cell death.) Conversely, [@B164] reported age-related decreases in the activities of cathepsins D, Ce1, and Ce2 in *C. elegans*. Finally, [@B8], measuring cathepsin D in 50 brain regions of adult and older individuals, found the levels of this enzyme to be significantly increased with age in 14 regions and decreased in two regions. The findings in these studies suggest that an age-related decline in lysosomal function is not necessarily accompanied by decreases in the activities of lysosomal proteases.

Discussion and Conclusion
=========================

Autophagic processes have often been stated to decrease with age ([@B113]; [@B114]; [@B34]; [@B72]; [@B41]; [@B166]). This conclusion is supported by most studies that have examined this issue in experimental systems other than the CNS ([Tables 4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}). The literature also suggests an age-related decline in macroautophagy in the CNS in experimental models, particularly *C. elegans, Drosophila*, and mice ([Table 2](#T2){ref-type="table"}). But because of the few studies on this issue in the human CNS ([Table 1](#T1){ref-type="table"}), no conclusion is currently possible as to whether autophagic processes in human brain decrease with normal aging, despite indirect evidence for this possibility from the studies in experimental systems. A similar conclusion was reached in a recent review by [@B64] of the connection between macroautophagy and longevity: "...further work is required to more rigorously test the hypothesis that autophagic activity may decline in an age-dependent fashion in the nervous system."

The three gene expression studies which have investigated this issue in human brain found age- associated decreases in macroautophagy proteins, although the study by [@B61] suggested differences between men and women for these parameters. However, confirmation that macroautophagy decreases in human brain during normal aging requires similar results with other methodologies. The lack of studies on age-associated changes in CMA in human brain specimens is a critical gap in the literature; unfortunately, the few CSF studies on this issue do not help to resolve the situation. Although the study by [@B7] found the concentrations of three autophagy-related proteins to correlate with age, none of the proteins plays a major role in autophagy. The reports of an age-associated decrease in CSF HSPA8/hsc70 ([@B107]) and no change with normal aging in CSF lamp2 levels ([@B106]) provide no information about the effects of aging on specific autophagic mechanisms in the CNS. HSPA8/hsc70 participates in many processes in addition to CMA ([@B175]; [@B102]) and measurement of total lamp2 is not specific for a particular autophagic mechanism. CSF studies are unlikely to be of value for determining the effects of aging on brain autophagy because (a) changes in the CSF concentration of a protein may not correlate with changes in its brain concentration, (b) the levels of autophagy-related proteins in CSF provide no information about their concentrations on lysosomal membranes; (c) it is unclear if the markers commonly used to assess changes in autophagic processes can be detected in CSF; and (d) measurement of the LC3-II/LC3-I ratio in the presence of inhibitors of lysosomal proteases or autophagosomal-lysosomal fusion is not possible in humans.

Some of these same issues raise concerns about the findings in the studies that have examined the effects of aging on brain autophagic processes in vertebrate models. Many of the studies on age-related changes in macroautophagy in experimental systems ([Table 2](#T2){ref-type="table"}) included measurements of total LC3, LC3-II, or the LC3-II/LC3-I ratio. The results in most of these studies are difficult to interpret with regard to autophagic flux because autophagic inhibitors were not included (exceptions: [@B83]; [@B154]; [@B182]; [@B146]), and because they represent findings at only one time point. None of the studies on rat brain listed in [Table 3](#T3){ref-type="table"} (effects of normal aging on CNS CMA in experimental systems) were performed on lysosome-enriched fractions, so the extent to which the reported levels of HSPA8/hsc70 reflected lysosomal concentrations of this protein is unknown. An inherent difficulty with comparing autophagy studies between different models is that basal autophagic activity in experimental animals can vary according to age, sex, and genetic background ([@B90]).

Comprehensive reviews of methods for assessing macroautophagy and CMA have recently been published ([@B147]; [@B90]). Appropriate procedures for investigating the effects of aging on these processes in the brain include transmission electron microscopy (TEM), western blot, immunohistochemical and immunofluorescent staining, and gene expression analyses. Combinations of these methods should be used ([@B90]). In addition to potential difficulties with data interpretation resulting from agonal changes and postmortem autolysis, studies on postmortem brain specimens provide only a "snapshot" of autophagic activity at a single time point, with no information about autophagic flux. TEM can detect and quantify morphological changes in autophagosomes, autolysosomes, amphisomes, and sequestered organelles ([@B53]). Western blot is often used for examining changes in LC3-I and LC3-II levels ([@B180]), but there are some caveats to the use of this procedure: (a) the concentration of LC3-I is higher than LC3-II in the brain, so LC3-II may be difficult to detect by western blot in crude homogenates ([@B29]; [@B200]); (b) LC3-I is more susceptible than LC3-II to degradation in SDS sample buffer or by exposure to freeze/thaw cycles; and (c) LC3-II levels measured by western blot should be compared to the levels of one or more loading control proteins rather than to LC3-I ([@B90]). Specific markers for CMA are presently limited to lamp2a and HSPA8/hsc70, but only the lysosomal membrane levels of these proteins correlate with CMA activity so their detection by Western blot or RT-PCR ([@B207]; [@B80]) should optimally be performed on lysosome-enriched fractions ([@B90]). Immunodetection of lamp2a should be done with antibodies which are specific for lamp2a ([@B147]).

Determining whether autophagic mechanisms decrease in the brain during normal aging has important clinical ramifications. Lifestyle modifications such as caloric restriction ([@B130]; [@B155]; [@B156]) and exercise ([@B71]) have been shown to increase autophagic activity in experimental animals. Exercise reduces brain pathology in some mouse models of PD ([@B96]; [@B148]) and AD ([@B3]; [@B138]; [@B187]), perhaps by induction of autophagy. Note, however, that a study in the P301S mouse model of tauopathy which examined the influence of long-term exercise on autophagy as well as tau pathology found reduced levels of full-length and hyperphosphorylated tau in the hippocampus and spinal cord despite no significant changes in the concentrations of LC3-II or p62/SQSTM1 ([@B142]), suggesting that the neuroprotective effects of exercise in that study may have been due to factors other than induction of macroautophagy. Exercise can also exert neuroprotective effects by increasing synaptic protein levels, cell proliferation, and neurotrophic factors in the brain ([@B128]; [@B137]; [@B75]; [@B112]). In transgenic mouse models of AD, reversal of autophagic deficits reduces brain Aβ deposition and prevents learning and memory deficits ([@B19]; [@B172]; [@B200]; [@B173]), and a reduction in α-synuclein aggregation and mitochondrial dysfunction has been found when autophagy is increased in experimental animal models of PD (reviewed by [@B129]). Taken together, these findings suggest that pharmacologic interventions and/or lifestyle alterations which increase brain autophagy might be useful for treatment and possibly even prevention of age-associated neurodegenerative disorders. The development of autophagy-inducing agents is an active field of research (reviewed by [@B99]; [@B190]). This approach is not without risk, because autophagy has been associated with increased tumor cell survival in some studies (reviewed by [@B59]). Further, in patients with impairments in autophagosomal-lysosomal fusion, such as AD patients with presenilin gene mutations ([@B98]), treatment with autophagy- inducing agents might produce further accumulation of neurotoxic polyubiquitinated protein aggregates ([@B99]). Nevertheless, if autophagic mechanisms can be conclusively shown to decrease in the brain during normal aging, then interventions to prevent this decrease might reduce the risk for some age-related neurodegenerative disorders, as suggested by [@B41] and [@B109].
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